Periodic Reporting for period 1 - LUCERO-BIO (LUCERO BIO: Smart Optofluidic Isolation of Spheroids for Early-Stage Drug Discovery)

Lucero is working on a novel AI-assisted cell handling platform with the goal of enabling the scalable use of 3D culture in pharmaceutical drug discovery. Personalised medicine can address variations of drug efficacy and toxicity linked to different patient subgroups...